FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

10423011000001103: Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
35783901000001111 Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
52464001000001110 Aclasta 5mg/100ml infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Is a Zoledronic acid 5mg/100ml solution for injection bottles 1 bottle true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Is pack of Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) false Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Has active ingredient Zoledronic acid false Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Has active ingredient Zoledronic acid monohydrate false Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Has manufactured dose form Solution for injection false Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Has AMP Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Zoledronic acid true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Has specific active ingredient Zoledronic acid monohydrate false Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Has dispensed dose form Infusion true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Has basis of strength substance Zoledronic acid true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Has specific active ingredient Zoledronic acid hydrate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start